See more news releases in Biotechnology | Health Care & Hospitals | Medical Pharmaceuticals | Pharmaceuticals | Trade Show

Cambrex To Present At Jefferies 2012 Global Healthcare Conference

EAST RUTHERFORD, N.J., May 15, 2012 /PRNewswire/ -- Cambrex Corporation (NYSE: CBM, "Cambrex") is pleased to announce that Steve Klosk , President and Chief Executive Officer, will make a presentation on the Company at the Jefferies 2012 Global Healthcare Conference on June 4, 2012 at 9:30 AM EDT in New York City.

The audio webcast and slide presentation can be accessed for 30 days from the Jefferies website at http://www.wsw.com/webcast/jeff68/cbm or the Cambrex website for 90 days at http://www.cambrex.com in the Investors section of the website under Webcasts & Presentations.

About Cambrex
Cambrex Corporation is an innovative life sciences company that provides products, services and technologies to accelerate the development and commercialization of small molecule therapeutics. We offer Active Pharmaceutical Ingredients (APIs), advanced intermediates and enhanced drug delivery products for branded and generic pharmaceuticals. Our development and manufacturing capabilities include enzymatic biotransformations, high potency APIs, high energy chemical synthesis, controlled substances and formulation of finished dosage form products. For more information, please visit www.cambrex.com.

SOURCE Cambrex Corporation